Institute of Physiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
German Centre for Cardiovascular Research (DZHK), partner site Berlin, 10117, Berlin, Germany.
Cell Tissue Res. 2020 May;380(2):379-392. doi: 10.1007/s00441-020-03172-2. Epub 2020 Feb 3.
Traditionally, the lung has been excluded from the ultrasound organ repertoire and, hence, the application of lung ultrasound (LUS) was largely limited to a few enthusiastic clinicians. Yet, in the last decades, the recognition of the previously untapped diagnostic potential of LUS in intensive care medicine has fueled its widespread use as a rapid, non-invasive and radiation-free bedside approach with excellent diagnostic accuracy for many of the most common causes of acute respiratory failure, e.g., cardiogenic pulmonary edema, pneumonia, pleural effusion and pneumothorax. Its increased clinical use has also incited attention for the potential usefulness of LUS in preclinical studies with small animal models mimicking lung congestion and pulmonary edema formation. Application of LUS to small animal models of pulmonary edema may save time, is cost-effective, and may reduce the number of experimental animals due to the possibility of serial evaluations in the same animal as compared with traditional end-point measurements. This review provides an overview of the emerging field of LUS with a specific focus on its application in animal models and highlights future perspectives for LUS in preclinical research.
传统上,肺部被排除在超声器官之外,因此,肺部超声(LUS)的应用在很大程度上仅限于少数热情的临床医生。然而,在过去几十年中,人们认识到 LUS 在重症监护医学中的未被开发的诊断潜力,推动了其广泛应用,成为一种快速、非侵入性和无辐射的床边方法,对许多常见的急性呼吸衰竭原因具有出色的诊断准确性,例如心源性肺水肿、肺炎、胸腔积液和气胸。它的临床应用增加也引起了人们对其在模拟肺部充血和肺水肿形成的小动物模型的临床前研究中的潜在用途的关注。与传统终点测量相比,将 LUS 应用于肺水肿小动物模型可以节省时间、具有成本效益,并且由于可以在同一只动物上进行连续评估,因此可以减少实验动物的数量。这篇综述介绍了 LUS 的新兴领域,并特别关注其在动物模型中的应用,并强调了 LUS 在临床前研究中的未来前景。